med-tech recap preview
med-tech updat framework
review call ortho expert call
result commentari ew result
med-tech updat framework review call et
pleas join us april et updat best idea given evolv
potenti improv trend elect surgeri use
framework assess differ scenario compani univers updat
thought project valuat us dial-in number
cs expert call elect surgeri et pleas join us
april anoth expert call confer call seri impact
ortho elect surgeri trend va importantli way hospit
think priorit surgeri volum open back us dial-in number
ew earn expect ew report bil sale
organ ep topic impact tavr volum
protocol perform tavr lock impact trial pipelin
intra-quart updat expect provid updat potenti impact
busi trend next week two like end
expect survey respond expect elect surgeri resum
mid-jun increas confid earli mid-may respond rank
least affect
may june updat interact framework assess
risk coverag univers allow paramet uncertainti
ms index ytd bp bp ms
ltm vs ms led group week
ytd lc growth diversifi ms
ntm ev/ebitda respect vs
figur weekli perform suppli devic ms
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
figur upcom event catalyst
updat framework review call
ticker potenti implic
read-through cardio
american associ neurolog surgeon aan
read-through cardio ew
read-through ortho spine
american associ hip knee surgeon spring meet
read-through spine
read-through spine
read-through ortho spine
pediatr orthopaed societi north america san diego
symposium advanc wound spring meet
postpon august
may june updat interact framework assess
risk coverag univers allow paramet uncertainti face
investor environ
ppe expert call take-away result unpreced surg
demand mask elect procedur could potenti restart month
ppe shortag begin eas hospit also eager restart profit procedur
impact management provid detail comprehens guidanc potenti impact
sale estim led three busi guidanc
lower contempl reiter outperform
result cse consensu rais target price
manag deliv solid beat vs expect consensu see
wave new test signific new growth driver next
year increas estim beyond reflect impact
new test rais target price reiter outperform
preliminari result view elect surgeri direct consist
management expect deferr elect surgeri signific impact
sale potenti declin rel consist rang pressur
elect procedur outlin reiter outperform
holt weekli analysi ew rank
ew rank attract coverag univers holt analysi also suggest
med-tech recap preview
valuat remain attract healthcar subsector put med-tech fairli
confer call event detail
updat framework review confer call
updat call expert ppe suppli manufactur confer replay
detail expir midnight et
figur week read research medic suppli devic
wave test approv drive increas volum diag sale growth rais target price
 medic suppli devic highlight
comprehens transpar view potenti impact help eas uncertainti reiter outperform
jan feb sale scrip trend analysi confirm upsid us pharma reiter outperform
tavr expert call impact tavr elect procedur defer durat triag protocol uncertain expect
revisit week
tavr surgeri interim protocol tavr patient emerg elect surgeri patient visit move
ep strong sale may better posit weather pandem reiter outperform
med-tech recap preview
outperform-r ew report result april model sale bil
cc organ ep vs consensu bil topic
call ou tavr growth procedur volum elect procedur
defer tavr growth expect post mitral tricuspid updat
updat clinic trial ew high exposur deferr procedur
expect higher acuiti procedur get back calendar faster
encourag investor flex assumpt revis interact model allow
number paramet uncertainti
announc launch lab-bas antibodi blood test
april announc launch igg test third
test lab-bas serolog blood test detect
antibodi igg identifi person novel coronaviru covid-
igg test identifi igg antibodi protein
bodi produc late stage infect may remain
month possibl year person recov abt igg antibodi test
initi avail architect laboratori
instrument
use
 laboratori instrument run test per hour
compani expect ship close mil test week custom
ship total mil test total april compani expect ramp
mil test june expand test run new alin
system also expect expand laboratori antibodi test
detect antibodi igm near futur new test come addit
abt id molecular point-of-car platform well abt test
med-tech recap preview
guidancecon cs estimate guidancecon cs estimate con cs growth growth growth growth growth growth growth growth growth growth growth growth growth growth growth variou clinic trial well pascal uptak physician train eupotenti benefit underli tavr sale procedur growth market share amidst tavr deferralsfocu adopt premium aortic valv updat inspiri resilia aortic valv launchexpect ep revenu guidanc charl martineau pm univers toronto
alc withdraw guidanc delay dividend april alc
announc withdraw guidanc due uncertainti around
impact given deferr eye care procedur exam
order maintain financi flexibl preserv cash compani also
delay initi dividend propos expect get
updat may compani report result
feder circuit vacat remand lower court rule find certain
claim nvro patent invalid litig april
feder circuit vacat remand district court judgment invalid
claim patent claim
patent claim patent claim
patent context su alleg infring eighteen
juli
district court issu joint claim construct summari judgment order
hold invalid indefinit claim patent
claim patent claim patent
claim patent district court held remain six
assert claim indefinit district court grant summari
judgment non-infring appeal district court judgment
invalid cross-app district court determin
remain six assert claim indefinit case corp
boston scientif corp us court appeal feder circuit
guidanc due evolv natur continu uncertainti result
pandem compani hold earn call may
announc revenu mil vs cse mil repres
declin organ compani state surgic
procedur declin significantli march healthcar provid realloc
resourc expect impact restrict surgic procedur
shelter-in-plac polici substanti neg impact
compani report result may
increas medicar payment high-product coronaviru lab
test april announc medicar nearli doubl payment
certain lab test use high-throughput technolog rapidli diagnos larg
number case medicar pay higher payment
test make use high-throughput
technolog develop privat sector allow increas test
capac faster result effect mean combat spread
viru context high-throughput lab test process
two hundr specimen day use equip requir special train
technician time-intens process assur qualiti medicar
pay laboratori test effect april
durat nation emerg lab test
current pay
approxim test exampl high throughput technolog
med-tech recap preview
includ abt roch coba system holx
panther fusion dhr genexpert infin
fda clear decontamin process could clean
million mask per day april fda issu emerg use
author eua advanc steril product asp sterrad
steril cycl use vapor hydrogen peroxid ga plasma
steril context sterrad steril system
hospit across reprocess time vari
minut system reprocess respir per day around mil
respir per day reus health care
fda grant first tent approv opsumit gener april
fda grant tent approv ta anda macitentan
submit season biotechnolog taizhou co ltd fda april
fda also grant tent approv ta anda macitentan
submit teva pharmaceut recal januari actelion
pharmaceut ltd initi patent infring lawsuit unit state
district court district new jersey usa
inc amneal pharmaceut llc file anda seek
approv market gener version opsumit expir unit
state patent patent lawsuit actelion
seek order enjoin zydu amneal market gener version
opsumit expir patent amneal zydu stipul
infring februari actelion amneal enter settlement
agreement trial zydu schedul commenc octob
juli actelion file suit aurobindo pharma usa inc
aurobindo pharma limit aurobindo file anda seek approv market
gener version opsumit expir patent actelion
seek order enjoin defend market gener version
opsumit expir patent trial aurobindo
schedul commenc juli context patent set
expir decemb
prisma health collabor ventil expans devic
april prisma health announc today collabor jnj ethicon
divis make distribut ventil expans devic call vesper
ventil expans splitter vesper ventil expans splitter
author emerg use allow singl ventil fit
ventil splitter use two rescuabl patient ventilatori support
pandem individu ventil avail use
print ethicon manufactur distribut vesper ventil expans
splitter cost healthcar provid eua
pre-announc revenu mil vs cse
mil reflect impact ww declin elect procedur start mid-
march result compani also withdrew guidanc
expect declin elect procedur volum continu signific
neg impact management also take temporari action reduc opex
includ compens reduct board director execut
offic control discretionari spend adjust manufactur capac
compani host earn call may
med-tech recap preview
pre-announc revenu mil vs cse
mil compani expect awc revenu mil
vs cse mil ssm revenu mil
vs cse mil purapli sale expect
rang mil vs cse mil compani
also withdrew guidanc report result may
phg ventil product combat april
phg announc team govern increas
product hospit ventil manufactur site phg
plan doubl product may achiev four-fold increas
suppli global market
withdraw guidanc provid color april
announc expect revenu cc
report vs cse compani also expect declin
elect procedur volum signific neg impact
compani also withdrew guidanc expect provid
comprehens updat may report result compani
also take step reinforc busi continu manufactur facil
overal suppli chain modul manufactur output implement
compens reduct leadership team board presid
ceo bryan hanson forgo salari
med-tech recap preview
figur last week med-tech bp bp bp hc
med-tech recap preview
figur last month disrupt ms lead ms
med-tech recap preview
figur last month disrupt ms index outperform smid lc
disrupt ms index pro-rata weight perform alc ew base
proport revenu driven disrupt technolog
med-tech recap preview
figur ntm ev/ebitda coverag univers
med-tech recap preview
med-tech recap preview
holt market impli expect analysi indic valuat conserv
healthcar subsector holt use revers dcf quantifi market impli
expect calcul futur level return capit cfroi requir justifi
today valuat market impli expect green dot consensu
forecast pink bar indic attract valuat upsid potenti stock
figur healthcar holt cfroi ntm forecast return capit vs market-impli spread
note aggreg ex financi regul util reit data shown base constitu median
med-tech recap preview
return capit cfroi histor forecast market impli median industryspread forecast vs market impli return capitalconserv expect current price impli declin returnsdemand expect current price impli increas ittot hclife scimedtechcfroi year mediancfroi lfycfroi consensu forecast ntm market impli ittot hclife scimedtechposit spread currentneg spread year median charl martineau pm univers toronto april
market impli expect coverag univers med-tech gener demand
rel sell side forecast holt market impli expect analysi reveal
attract consensu forecast cfroi market impli
expect demand expect
figur med-tech holt cfroi ntm forecast return capit vs market-impli spread
contact inform holt
med-tech recap preview
spread currentneg spread year median mediancfroi lfycfroi consensu forecast ntm market impli cfroireturn capit cfroi histor forecast market impliedspread forecast vs market impli return capit conserv expect current price impli declin returnsdemand expect current price impli increas charl martineau pm univers toronto
compani mention price
